Medical professionals in the UAE are raising concerns that patients relying on popular weight-loss injections like Ozempic, Mounjaro, and Wegovy are often celebrating the wrong metrics. While these medications are highly effective at reducing body weight, the rapid shedding of kilograms often comes at the expense of lean muscle tissue rather than just unwanted fat. Doctors emphasize that a scale’s downward trend does not guarantee improved health; if patients fail to consume enough protein, stay hydrated, or engage in consistent physical activity, they risk losing the very muscle mass required for strength, mobility, and long-term metabolic function.

To combat these risks, specialists are shifting the focus from simple weight reduction to comprehensive body composition management. Clinical experts now utilize tools like Dexa scans and bioelectrical impedance analysis to distinguish between fat loss and muscle atrophy. By working alongside dietitians, doctors are urging patients to prioritize a high-protein diet and structured exercise routines—typically 150 minutes of moderate activity per week—to protect their physical function. Ultimately, physicians stress that these medications should only be used under strict medical supervision to ensure that the journey toward a lower weight does not compromise the body's structural integrity or future independence.